Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-01-25
2011-01-25
Martinell, James (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100
Reexamination Certificate
active
07875431
ABSTRACT:
The present invention provides for a method of detecting the presence of inflammatory bowel disease in gastrointestinal tissues or cells of a mammal by detecting increased expression of LY6 genes in the tissues or cells of the mammal relative to a control.
REFERENCES:
patent: 7144990 (2006-12-01), Goddard et al.
patent: 7157558 (2007-01-01), Goddard et al.
patent: WO 00/61629 (2000-10-01), None
patent: WO 00/77026 (2000-12-01), None
Database Gene Sequence Online,Human Secreted Protein Gene 13 SEQ IDNo. 23, XP002489471, Apr. 6, 2001.
Database Gene Sequence Online,Human Secreted Protein Gene 28 SEQ IDNo. 38, XP002489472, Mar. 26, 2001.
Apostolopoulos, et al., “Ly6d-L, a cell surface ligand for mouse Ly6d”, Immunity, vol. 12, pp. 223-232, (2000).
Baksheev, et al., Gene expression in the adapting small bowel after massive small bowel resection, J. Gastroenterol, 41: 1041-1052, (2006).
Bamezai, “Mouse Ly-6 proteins and their extended family: markers of cell differentiation and regulators of cell signaling”, Arch. Immunol. Ther. Exp., 52: 255-266, (2004).
Banks, et al., “Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and crohn's disease”, J. Pathol., 199: 28-35, (2003).
Bohuslav, et al., “Large, detergent-resistant complexes containing murine antigens Thy-1 and Ly-6 and protein tyrosine kinase p56lck*”, Eur. J. Immunol., 23: 825-831, (1993).
Bouma, et al., “The immunological and genetic basis of inflammatory bowel disease”, Nature Reviews, vol. 3, pp. 521-533, (2003).
Brand, et al., “IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration”, Am. J. Physiol. Gastrointest. Liver Physiol., 290: G827-G838, (2006).
Breider, et al., “Intercellular adhesion molecule-1 expression in dextran sodium sulfate-induced colitis in rats”, Vet. Pathol., 34: 598-604, (1997).
Chou, et al., “The Caenorhabditis elegans ord-2 gene encodes a novel Ly-6-related protein required for Olfaction”, Genetics, 157: 211-224, (2001).
Dieckgraefe, et al., “Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays”, Physiol. Genomics, 4: 1-11, (2000).
Dooley, et al., “Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs”, Inflamm. Bowel Dis., vol. 10, No. 1, pp. 1-14, (2004).
Elson, et al., “Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota”, Immunological Reviews, vol. 206, pp. 260-276, (2005).
Fahlgren, et al., “β-defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis”, Clin. Exp. Immunol., 137: 379-385, (2004).
Henderson, et al., “Ly-6A.2 expression regulates antigen-specific CD4+T cell proliferation and cytokine production1”, The Journal of Immunology, 168: 118-126, (2002).
Hidalgo, et al., “Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44”, Immunity, 26: 477-489, (2007).
Jaakkola, et al., “Ly6c induces clustering of LFA-1 (CD11a/CD18) and is involved in subtype-specific adhesion of CD8 T cells1”, The Journal of Immunology, 170: 1283-1290, (2003).
Khodadoust, et al., “Complex regulation of Ly-6E gene transcription in T cells by IFNs1”, The Journal of Immunology, 163: 811-819, (1999).
Lawrance, et al., “Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes”, Human Molecular Genetics, vol. 10, No. 5, pp. 445-456, (2001).
Niessner, et al., “Altered Thl/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)”, Clin. Exp. Immunol., 101: 428-435, (1995).
Papadakis, “Chemokines in inflammatory bowel disease”, Current Allergy and Asthma Reports, 4: 83-89, (2004).
Papadakis, et al., “The role of chemokines and chemokine receptors in mucosal inflammatory”, Inflammatory Bowel Diseases, 6(4): 303-313, (2000).
Paret, et al., “Ly6 family member C4.4A binds laminins 1 and 5, associates with Galectin-3 and supports cell migration”, Int. J. Cancer, 115: 724-733, (2005).
Podolsky, “Inflammatory bowel disease”, N. Eng. J. Med., vol. 347, No. 6, pp. 417-429, (2002).
Rock, et al., “The LY-6 locus: A multigene family encoding phosphatodylinositol-Anchored membrane proteins concerned with T-cell activation”, Immunological Reviews, No. 111, pp. 195-224, (1989).
Ruiz, et al., “IL-10 gene-deficient mice lack TGF-β/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic enterococcus faecalis”, The Journal of Immunology, 174: 2990-2999, (2005).
Shao, et al., “Non-classical MHC class 1 molecules on intestinal epithelial cells: mediators of mucosal crosstalk”, Immunological Reviews, vol. 206, pp. 160-176, (2005).
Shevach, et al., “Ly-6: a multigene family in search of a function”, Immunology Today, vol. 10, No. 6, pp. 195-200, (1989).
Simons, et al., “Cholesterol, lipid rafts, and disease”, The Journal of Clinical Investigation, vol. 110, No. 5, pp. 597-603, (2002).
Simons, et al., “Lipid rafts and signal transduction”, Nature Reviews, vol. 1, pp. 31-41, (2000).
Singh, et al., “Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis”, Am. J. Physiol. Gastrointest Liver Physiol., 288: G514-G524, (2005).
Snoeck, et al., “The role of enterocytes in the intestinal barrier function and antigen uptake”, Microbes and Infection, 7: 997-1004, (2005).
Sunderkotter, et al., “Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response”, The Journal of Immunology, 172: 4410-4417, (2004).
Uguccioni, et al., “Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis”, American Journal of Pathology, vol. 155, No. 2, pp. 331-336, (1999).
Uthoff, et al., “Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology”, International Journal of Oncology, 19: 803-810, (2001).
Von Tresckow, et al., “Depletion of cellular cholesterol and lipid rafts increases shedding of CD301”, The Journal of Immunology, 172: 4324-4331, (2004).
Wolk, et al., “IL-22 induces lipopolysaccharide-binding protein in hepatocytes: A potential systemic role of IL-22 in Crohn's disease”, The Journal of Immunology, 178: 5973-5981, (2007).
Z'Graggen, et al., “The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease”, Gastroenterology, 113: 808-816, (1997).
Zhang, et al., “Ly-6A is critical for the function of double negative regulatory T cells”, Eur. J. Immunol., 32: 1584-1592, (2002).
Diehl Lauri
Flanagan Kenneth
Mo Lian
Arnold & Porter LLP
Bernhardt Jeffrey P.
Genentech Inc.
Martinell James
Svoboda Craig
LandOfFree
Methods for detecting inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting inflammatory bowel disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2632122